Record number of applications received
Ovarian Cancer Research Alliance (OCRA) announced today that it will invest more than $6 million in research initiatives in 2025, which includes promising projects targeting recurrence, treatment resistance, outcome disparities and other challenges faced by our community.
These grantees were selected from a record number of applicants via a competitive review process led by our Scientific Advisory Committee.
“OCRA is proud to support this gifted group of scientists who are resolute in their pursuit of breakthroughs to better understand and treat these cancers,” said Audra Moran, OCRA’s President & CEO.
OCRA is the world’s largest organization combating ovarian and all gynecologic cancers through groundbreaking research, impactful advocacy, and unparalleled patient support while forging new paths in prevention, education, and awareness.
OCRA is grateful for the dedicated scientists steadfastly devoted to fighting these diseases and the support of all who made this funding of their work possible.
We look forward to sharing more about our 2025 grantees and their groundbreaking projects in the months ahead.
